AQST(Aquestive Therapeutics, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $50.83M | $47.68M | $50.58M | $57.56M | $44.55M |
| 毛利润 | — | $28.29M | $29.75M | $39.69M | $25.99M |
| 营业利润 | −$34.68M | −$42.07M | −$15.10M | −$30.77M | −$71.05M |
| 净利润 | −$70.54M | −$54.41M | −$7.87M | −$44.14M | −$83.78M |
| 经营现金流 | −$32.98M | −$9.82M | −$6.38M | −$35.76M | −$52.43M |
| 自由现金流 | −$33.89M | −$10.84M | −$7.38M | −$35.92M | −$52.99M |
| 摊薄每股收益 | $-1.85 | $-1.12 | $-0.13 | $-0.51 | $-0.78 |